208 related articles for article (PubMed ID: 25269767)
21. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.
Schetter AJ; Leung SY; Sohn JJ; Zanetti KA; Bowman ED; Yanaihara N; Yuen ST; Chan TL; Kwong DL; Au GK; Liu CG; Calin GA; Croce CM; Harris CC
JAMA; 2008 Jan; 299(4):425-36. PubMed ID: 18230780
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of microRNA-1 and microRNA-145 contributes synergistically to the development of colon cancer.
Xu X; Wu X; Jiang Q; Sun Y; Liu H; Chen R; Wu S
Int J Mol Med; 2015 Dec; 36(6):1630-8. PubMed ID: 26459459
[TBL] [Abstract][Full Text] [Related]
23. FBXW7 mediates chemotherapeutic sensitivity and prognosis in NSCLCs.
Yokobori T; Yokoyama Y; Mogi A; Endoh H; Altan B; Kosaka T; Yamaki E; Yajima T; Tomizawa K; Azuma Y; Onozato R; Miyazaki T; Tanaka S; Kuwano H
Mol Cancer Res; 2014 Jan; 12(1):32-7. PubMed ID: 24165483
[TBL] [Abstract][Full Text] [Related]
24. p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases.
Yokobori T; Mimori K; Iwatsuki M; Ishii H; Onoyama I; Fukagawa T; Kuwano H; Nakayama KI; Mori M
Cancer Res; 2009 May; 69(9):3788-94. PubMed ID: 19366810
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.
Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L
Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944
[TBL] [Abstract][Full Text] [Related]
26. miR-23a promotes the transition from indolent to invasive colorectal cancer.
Jahid S; Sun J; Edwards RA; Dizon D; Panarelli NC; Milsom JW; Sikandar SS; Gümüs ZH; Lipkin SM
Cancer Discov; 2012 Jun; 2(6):540-53. PubMed ID: 22628407
[TBL] [Abstract][Full Text] [Related]
27. Investigation of miRNA dysregulation and association with immune cell profile during malignant transformation of colorectal cells.
Ng L; Li X; Wan TM; Iyer D; Sin RW; Lo OS; Foo DC; Law WL
Eur J Surg Oncol; 2022 Jan; 48(1):245-252. PubMed ID: 34620510
[TBL] [Abstract][Full Text] [Related]
28. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
29. FBXW7 mutation analysis and its correlation with clinicopathological features and prognosis in colorectal cancer patients.
Chang CC; Lin HH; Lin JK; Lin CC; Lan YT; Wang HS; Yang SH; Chen WS; Lin TC; Jiang JK; Chang SC
Int J Biol Markers; 2015 Feb; 30(1):e88-95. PubMed ID: 25450649
[TBL] [Abstract][Full Text] [Related]
30. The FBXW7 beta-form is suppressed in human glioma cells.
Gu Z; Inomata K; Ishizawa K; Horii A
Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947
[TBL] [Abstract][Full Text] [Related]
31. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma.
Li Z; Xiao J; Hu K; Wang G; Li M; Zhang J; Cheng G
Int J Mol Sci; 2015 Jan; 16(2):2294-306. PubMed ID: 25622249
[TBL] [Abstract][Full Text] [Related]
32. Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells.
Rodrigues S; Rodrigue CM; Attoub S; Fléjou JF; Bruyneel E; Bracke M; Emami S; Gespach C
Oncogene; 2006 Oct; 25(50):6628-36. PubMed ID: 16715141
[TBL] [Abstract][Full Text] [Related]
33. Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas.
Snijders AM; Liu Y; Su L; Huang Y; Mao JH
Oncotarget; 2015 Dec; 6(42):44794-805. PubMed ID: 26575021
[TBL] [Abstract][Full Text] [Related]
34. miR-223-RhoB signaling pathway regulates the proliferation and apoptosis of colon adenocarcinoma.
Wei LJ; Li JA; Bai DM; Song Y
Chem Biol Interact; 2018 Jun; 289():9-14. PubMed ID: 29660302
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs associated with initiation and progression of colonic polyp: a feasibility study.
Aslam MI; Hussein S; West K; Singh B; Jameson JS; Pringle JH
Int J Surg; 2015 Jan; 13():272-279. PubMed ID: 25496852
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-21 and PDCD4 expression in colorectal cancer.
Chang KH; Miller N; Kheirelseid EA; Ingoldsby H; Hennessy E; Curran CE; Curran S; Smith MJ; Regan M; McAnena OJ; Kerin MJ
Eur J Surg Oncol; 2011 Jul; 37(7):597-603. PubMed ID: 21546206
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer.
Smith K; Bui TD; Poulsom R; Kaklamanis L; Williams G; Harris AL
Br J Cancer; 1999 Oct; 81(3):496-502. PubMed ID: 10507776
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancers.
Chandramouli A; Onyeagucha BC; Mercado-Pimentel ME; Stankova L; Shahin NA; LaFleur BJ; Heimark RL; Bhattacharyya AK; Nelson MA
Cancer Biol Ther; 2012 Feb; 13(3):175-83. PubMed ID: 22353936
[TBL] [Abstract][Full Text] [Related]
39. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.
Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS
Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929
[TBL] [Abstract][Full Text] [Related]
40. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
